Lyra Therapeutics Inc
Biotechnology
Healthcare
LYRA
1.32 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.43
52 week high
27.58
high
6.77
52 week low
0.00
previous Close
6.42
P/E ratio
market cap
12.07 M
div yield
0
net incoming
-8.55 M
22.15 %
net profit margin
-4670.49 %
582.00 %
operating incoming
-8.84 M
22.50 %
net change in cash
-8.84 M
-152.70 %
cash on hand
31.74 M
-21.79 %
top